Publicaciones en colaboración con investigadores/as de KU Leuven (34)

2024

  1. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

    JHEP Reports, Vol. 6, Núm. 2

  2. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

    Journal of Hepatology

  3. Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis

    Hepatology, Vol. 79, Núm. 3, pp. 624-635

  4. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding

    Journal of Hepatology, Vol. 80, Núm. 1, pp. 73-81

2023

  1. Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode

    Liver International, Vol. 43, Núm. 7, pp. 1548-1557

  2. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

  3. Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

    Transplantation, Vol. 107, Núm. 6, pp. 1330-1340

  4. Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

    Gut, Vol. 72, Núm. 8, pp. 1581-1591

2022

  1. Cirrhosis-associated immune dysfunction

    Nature Reviews Gastroenterology and Hepatology, Vol. 19, Núm. 2, pp. 112-134

  2. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease

    Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 10, pp. 2276-2286.e6

  3. Impact of Non-etiological Novel Therapies in the Course of Cirrhosis: Consensus Statements of Panel 4

    Portal Hypertension VII: Proceedings of the 7th Baveno Consensus Workshop: Personalized Care in Portal Hypertension (Springer International Publishing), pp. 321-323

2021

  1. A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation

    JHEP Reports, Vol. 3, Núm. 4

  2. Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis

    Journal of Hepatology, Vol. 75, Núm. 2, pp. 342-350

  3. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data

    Gastroenterology, Vol. 160, Núm. 1, pp. 193-205.e10

  4. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108

  5. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis

    Journal of Hepatology, Vol. 75, pp. S82-S100

2020

  1. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

    Journal of Hepatology, Vol. 72, Núm. 4, pp. 688-701

  2. Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701] (Journal of Hepatology (2020) 72(4) (688–701), (S0168827819306968), (10.1016/j.jhep.2019.11.009))

    Journal of Hepatology

  3. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

    Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091

  4. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Journal of Hepatology, Vol. 73, Núm. 4, pp. 842-854